ArticlePharmaceuticals (Basel, Switzerland)2018
The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation.
Guy A Richards et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it